NCT03208062 Banca di Materiale Biologico Per lo Studio di Patologie Che Interessano l'Apparato Muscolo-scheletrico
| NCT ID | NCT03208062 |
| Status | Recruiting |
| Phase | — |
| Sponsor | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
| Condition | Tissue Banking |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2017-05-31 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2017-05-31 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Musculoskeletal disorders are an heterogeneous group of diseases that represent one of the major causes of disability. Considering the importance of studying these pathologies, it is necessary to develop research lines based on the availability of human biological material from highly clinically relevant patients. The purpose of this project is therefore the establishment of a bank of biological material (biobank) to investigate important aspects related to the pathologies of the musculoskeletal system through subsequent bio-molecular characterization studies.
Eligibility Criteria
Inclusion Criteria: * Patients admitted to our Institute * Patients aged ≥18 years * Patients with osteoarthritis of hip or knee and rehabilitated in the institute * Patients with primary and secondary tumors of the skeleton * Patients undergoing prosthetic surgery following infection of the implant Exclusion Criteria: * Participants aged \<18 years * Participants unable to release the Informed Consent
Contact & Investigator
Giuseppe Banfi
PRINCIPAL INVESTIGATOR
IRCCS Istituto Ortopedico Galeazzi
Frequently Asked Questions
Who can join the NCT03208062 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tissue Banking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03208062 currently recruiting?
Yes, NCT03208062 is actively recruiting participants. Contact the research team at elena.cittera@grupposandonato.it for enrollment information.
Where is the NCT03208062 trial being conducted?
This trial is being conducted at Milan, Italy, Milan, Italy.
Who is sponsoring the NCT03208062 clinical trial?
NCT03208062 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. The principal investigator is Giuseppe Banfi at IRCCS Istituto Ortopedico Galeazzi. The trial plans to enroll 1,500 participants.